ID   PDK1_HUMAN              Reviewed;         436 AA.
AC   Q15118; B2R6T1; B7Z937; D3DPD8; E9PD65; Q308M4;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   12-APR-2017, entry version 161.
DE   RecName: Full=[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial;
DE            EC=2.7.11.2;
DE   AltName: Full=Pyruvate dehydrogenase kinase isoform 1;
DE            Short=PDH kinase 1;
DE   Flags: Precursor;
GN   Name=PDK1; Synonyms=PDHK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, CATALYTIC ACTIVITY,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=7499431; DOI=10.1074/jbc.270.48.28989;
RA   Gudi R., Bowker-Kinley M.M., Kedishvili N.Y., Zhao Y., Popov K.M.;
RT   "Diversity of the pyruvate dehydrogenase kinase gene family in
RT   humans.";
RL   J. Biol. Chem. 270:28989-28994(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Li H., Nong W., Zhou G., Ke R., Shen C., Zhong G., Zheng Z., Liang M.,
RA   Tang Z., Huang B., Lin L., Yang S.;
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION.
RX   PubMed=18541534; DOI=10.1074/jbc.M801765200;
RA   McFate T., Mohyeldin A., Lu H., Thakar J., Henriques J., Halim N.D.,
RA   Wu H., Schell M.J., Tsang T.M., Teahan O., Zhou S., Califano J.A.,
RA   Jeoung N.H., Harris R.A., Verma A.;
RT   "Pyruvate dehydrogenase complex activity controls metabolic and
RT   malignant phenotype in cancer cells.";
RL   J. Biol. Chem. 283:22700-22708(2008).
RN   [8]
RP   INDUCTION BY HYPOXIA.
RX   PubMed=21763680; DOI=10.1016/j.ajpath.2011.05.050;
RA   Lu C.W., Lin S.C., Chien C.W., Lin S.C., Lee C.T., Lin B.W., Lee J.C.,
RA   Tsai S.J.;
RT   "Overexpression of pyruvate dehydrogenase kinase 3 increases drug
RT   resistance and early recurrence in colon cancer.";
RL   Am. J. Pathol. 179:1405-1414(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   CATALYTIC ACTIVITY, FUNCTION, SUBCELLULAR LOCATION, AND
RP   PHOSPHORYLATION AT TYR-136; TYR-243 AND TYR-244.
RX   PubMed=22195962; DOI=10.1016/j.molcel.2011.10.015;
RA   Hitosugi T., Fan J., Chung T.W., Lythgoe K., Wang X., Xie J., Ge Q.,
RA   Gu T.L., Polakiewicz R.D., Roesel J.L., Chen G.Z., Boggon T.J.,
RA   Lonial S., Fu H., Khuri F.R., Kang S., Chen J.;
RT   "Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase
RT   kinase 1 is important for cancer metabolism.";
RL   Mol. Cell 44:864-877(2011).
RN   [11]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER PHE-28, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 30-436 IN COMPLEX WITH THE
RP   INHIBITORS AZD7545 AND DICHLOROACETATE, FUNCTION, SUBUNIT, CATALYTIC
RP   ACTIVITY, AND ENZYME REGULATION.
RX   PubMed=17683942; DOI=10.1016/j.str.2007.07.001;
RA   Kato M., Li J., Chuang J.L., Chuang D.T.;
RT   "Distinct structural mechanisms for inhibition of pyruvate
RT   dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and
RT   radicicol.";
RL   Structure 15:992-1004(2007).
RN   [13]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-412.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Kinase that plays a key role in regulation of glucose
CC       and fatty acid metabolism and homeostasis via phosphorylation of
CC       the pyruvate dehydrogenase subunits PDHA1 and PDHA2. This inhibits
CC       pyruvate dehydrogenase activity, and thereby regulates metabolite
CC       flux through the tricarboxylic acid cycle, down-regulates aerobic
CC       respiration and inhibits the formation of acetyl-coenzyme A from
CC       pyruvate. Plays an important role in cellular responses to hypoxia
CC       and is important for cell proliferation under hypoxia. Protects
CC       cells against apoptosis in response to hypoxia and oxidative
CC       stress. {ECO:0000269|PubMed:17683942, ECO:0000269|PubMed:18541534,
CC       ECO:0000269|PubMed:22195962, ECO:0000269|PubMed:7499431}.
CC   -!- CATALYTIC ACTIVITY: ATP + [pyruvate dehydrogenase (acetyl-
CC       transferring)] = ADP + [pyruvate dehydrogenase (acetyl-
CC       transferring)] phosphate. {ECO:0000269|PubMed:17683942,
CC       ECO:0000269|PubMed:22195962, ECO:0000269|PubMed:7499431}.
CC   -!- ENZYME REGULATION: Activity is enhanced by binding to the pyruvate
CC       dehydrogenase subunit DLAT. Inhibited by AZD7545; this compound
CC       interferes with DLAT binding and thereby inhibits kinase activity.
CC       Inhibited by dichloroacetate and radicicol.
CC       {ECO:0000269|PubMed:17683942}.
CC   -!- SUBUNIT: Homodimer, and heterodimer with PDK2. Interacts with the
CC       pyruvate dehydrogenase complex subunit DLAT, and is part of the
CC       multimeric pyruvate dehydrogenase complex that contains multiple
CC       copies of pyruvate dehydrogenase (E1), dihydrolipoamide
CC       acetyltransferase (DLAT, E2) and lipoamide dehydrogenase (DLD,
CC       E3). {ECO:0000269|PubMed:17683942}.
CC   -!- INTERACTION:
CC       P31749-1:AKT1; NbExp=2; IntAct=EBI-12562315, EBI-12562306;
CC       P31751-1:AKT2; NbExp=2; IntAct=EBI-12562315, EBI-12562336;
CC       Q16513:PKN2; NbExp=6; IntAct=EBI-7016221, EBI-2511350;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000269|PubMed:22195962}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15118-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15118-2; Sequence=VSP_055172;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in the heart. Detected
CC       at lower levels in liver, skeletal muscle and pancreas.
CC       {ECO:0000269|PubMed:7499431}.
CC   -!- INDUCTION: Up-regulated via the HIF1A signaling pathway in
CC       response to hypoxia. {ECO:0000269|PubMed:21763680}.
CC   -!- PTM: Phosphorylated by constitutively activated ABL1, FGFR1, FLT3
CC       and JAK2 (in vitro), and this may also occur in cancer cells that
CC       express constitutively activated ABL1, FGFR1, FLT3 and JAK2.
CC       Phosphorylation at Tyr-243 and Tyr-244 strongly increases kinase
CC       activity, while phosphorylation at Tyr-136 has a lesser effect.
CC       {ECO:0000269|PubMed:22195962}.
CC   -!- SIMILARITY: Belongs to the PDK/BCKDK protein kinase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42450; AAC42009.1; -; mRNA.
DR   EMBL; DQ234350; ABB29979.1; -; mRNA.
DR   EMBL; AK304388; BAH14173.1; -; mRNA.
DR   EMBL; AK312700; BAG35578.1; -; mRNA.
DR   EMBL; AC018712; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093818; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX11173.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11174.1; -; Genomic_DNA.
DR   EMBL; BC039158; AAH39158.1; -; mRNA.
DR   CCDS; CCDS2250.1; -. [Q15118-1]
DR   CCDS; CCDS63059.1; -. [Q15118-2]
DR   PIR; I55465; I55465.
DR   RefSeq; NP_001265478.1; NM_001278549.1. [Q15118-2]
DR   RefSeq; NP_002601.1; NM_002610.4. [Q15118-1]
DR   UniGene; Hs.470633; -.
DR   UniGene; Hs.733780; -.
DR   PDB; 2Q8F; X-ray; 2.03 A; A=30-436.
DR   PDB; 2Q8G; X-ray; 1.90 A; A=30-436.
DR   PDB; 2Q8H; X-ray; 2.00 A; A=30-436.
DR   PDBsum; 2Q8F; -.
DR   PDBsum; 2Q8G; -.
DR   PDBsum; 2Q8H; -.
DR   ProteinModelPortal; Q15118; -.
DR   SMR; Q15118; -.
DR   BioGrid; 111189; 58.
DR   DIP; DIP-29497N; -.
DR   IntAct; Q15118; 32.
DR   MINT; MINT-2881420; -.
DR   STRING; 9606.ENSP00000282077; -.
DR   BindingDB; Q15118; -.
DR   ChEMBL; CHEMBL4766; -.
DR   DrugBank; DB08809; Dichloroacetic Acid.
DR   GuidetoPHARMACOLOGY; 2915; -.
DR   iPTMnet; Q15118; -.
DR   PhosphoSitePlus; Q15118; -.
DR   DMDM; 3183117; -.
DR   EPD; Q15118; -.
DR   MaxQB; Q15118; -.
DR   PaxDb; Q15118; -.
DR   PeptideAtlas; Q15118; -.
DR   PRIDE; Q15118; -.
DR   DNASU; 5163; -.
DR   Ensembl; ENST00000282077; ENSP00000282077; ENSG00000152256. [Q15118-1]
DR   Ensembl; ENST00000392571; ENSP00000376352; ENSG00000152256. [Q15118-2]
DR   Ensembl; ENST00000410055; ENSP00000386985; ENSG00000152256. [Q15118-1]
DR   GeneID; 5163; -.
DR   KEGG; hsa:5163; -.
DR   UCSC; uc002uhs.5; human. [Q15118-1]
DR   CTD; 5163; -.
DR   DisGeNET; 5163; -.
DR   GeneCards; PDK1; -.
DR   HGNC; HGNC:8809; PDK1.
DR   HPA; CAB017554; -.
DR   HPA; HPA027376; -.
DR   HPA; HPA059083; -.
DR   MIM; 602524; gene.
DR   neXtProt; NX_Q15118; -.
DR   OpenTargets; ENSG00000152256; -.
DR   PharmGKB; PA33154; -.
DR   eggNOG; KOG0787; Eukaryota.
DR   eggNOG; COG0642; LUCA.
DR   GeneTree; ENSGT00550000074574; -.
DR   HOGENOM; HOG000164315; -.
DR   HOVERGEN; HBG000511; -.
DR   InParanoid; Q15118; -.
DR   KO; K12077; -.
DR   OMA; EDAKTIY; -.
DR   OrthoDB; EOG091G07DJ; -.
DR   PhylomeDB; Q15118; -.
DR   TreeFam; TF314918; -.
DR   BRENDA; 2.7.11.2; 2681.
DR   Reactome; R-HSA-204174; Regulation of pyruvate dehydrogenase (PDH) complex.
DR   Reactome; R-HSA-5362517; Signaling by Retinoic Acid.
DR   SignaLink; Q15118; -.
DR   SIGNOR; Q15118; -.
DR   EvolutionaryTrace; Q15118; -.
DR   GeneWiki; Pyruvate_dehydrogenase_lipoamide_kinase_isozyme_1; -.
DR   GenomeRNAi; 5163; -.
DR   PRO; PR:Q15118; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000152256; -.
DR   CleanEx; HS_PDK1; -.
DR   ExpressionAtlas; Q15118; baseline and differential.
DR   Genevisible; Q15118; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005967; C:mitochondrial pyruvate dehydrogenase complex; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0004740; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity; IDA:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IMP:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; TAS:ProtInc.
DR   GO; GO:0097411; P:hypoxia-inducible factor-1alpha signaling pathway; IMP:UniProtKB.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IMP:UniProtKB.
DR   GO; GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; IMP:UniProtKB.
DR   Gene3D; 1.20.140.20; -; 1.
DR   Gene3D; 3.30.565.10; -; 1.
DR   InterPro; IPR018955; BCDHK/PDK_N.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR005467; His_kinase_dom.
DR   Pfam; PF10436; BCDHK_Adom3; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF55874; SSF55874; 1.
DR   SUPFAM; SSF69012; SSF69012; 1.
DR   PROSITE; PS50109; HIS_KIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding;
KW   Carbohydrate metabolism; Complete proteome; Glucose metabolism;
KW   Kinase; Mitochondrion; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transferase; Transit peptide.
FT   TRANSIT       1     28       Mitochondrion.
FT                                {ECO:0000244|PubMed:25944712,
FT                                ECO:0000255}.
FT   CHAIN        29    436       [Pyruvate dehydrogenase (acetyl-
FT                                transferring)] kinase isozyme 1,
FT                                mitochondrial.
FT                                /FTId=PRO_0000023437.
FT   DOMAIN      163    393       Histidine kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00107}.
FT   NP_BIND     279    286       ATP. {ECO:0000250}.
FT   NP_BIND     337    338       ATP. {ECO:0000250}.
FT   NP_BIND     354    359       ATP. {ECO:0000250}.
FT   BINDING     318    318       ATP. {ECO:0000250}.
FT   MOD_RES     136    136       Phosphotyrosine; by FGFR1.
FT                                {ECO:0000269|PubMed:22195962}.
FT   MOD_RES     243    243       Phosphotyrosine; by FGFR1, ABL1, FLT3 and
FT                                JAK2. {ECO:0000269|PubMed:22195962}.
FT   MOD_RES     244    244       Phosphotyrosine; by FGFR1.
FT                                {ECO:0000269|PubMed:22195962}.
FT   MOD_RES     405    405       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BFP9}.
FT   VAR_SEQ     137    137       D -> ERPRRTWLQVSSLCCMACKMI (in isoform
FT                                2). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.2}.
FT                                /FTId=VSP_055172.
FT   VARIANT     134    134       A -> T (in dbSNP:rs35661499).
FT                                /FTId=VAR_050477.
FT   VARIANT     412    412       N -> T (in dbSNP:rs34250425).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042295.
FT   CONFLICT      8      8       R -> L (in Ref. 2; ABB29979).
FT                                {ECO:0000305}.
FT   CONFLICT     96     96       L -> R (in Ref. 3; BAH14173).
FT                                {ECO:0000305}.
FT   CONFLICT    363    363       R -> C (in Ref. 2; ABB29979).
FT                                {ECO:0000305}.
FT   HELIX        42     50       {ECO:0000244|PDB:2Q8G}.
FT   HELIX        59     67       {ECO:0000244|PDB:2Q8G}.
FT   HELIX        72     94       {ECO:0000244|PDB:2Q8G}.
FT   HELIX        99    102       {ECO:0000244|PDB:2Q8G}.
FT   HELIX       105    122       {ECO:0000244|PDB:2Q8G}.
FT   STRAND      125    127       {ECO:0000244|PDB:2Q8G}.
FT   HELIX       132    148       {ECO:0000244|PDB:2Q8G}.
FT   TURN        149    151       {ECO:0000244|PDB:2Q8G}.
FT   HELIX       152    166       {ECO:0000244|PDB:2Q8G}.
FT   HELIX       171    202       {ECO:0000244|PDB:2Q8G}.
FT   STRAND      219    224       {ECO:0000244|PDB:2Q8G}.
FT   HELIX       225    244       {ECO:0000244|PDB:2Q8G}.
FT   STRAND      250    259       {ECO:0000244|PDB:2Q8G}.
FT   STRAND      265    268       {ECO:0000244|PDB:2Q8G}.
FT   HELIX       270    291       {ECO:0000244|PDB:2Q8G}.
FT   TURN        293    295       {ECO:0000244|PDB:2Q8G}.
FT   STRAND      301    307       {ECO:0000244|PDB:2Q8G}.
FT   STRAND      309    318       {ECO:0000244|PDB:2Q8G}.
FT   HELIX       325    328       {ECO:0000244|PDB:2Q8G}.
FT   HELIX       329    332       {ECO:0000244|PDB:2Q8G}.
FT   TURN        334    337       {ECO:0000244|PDB:2Q8G}.
FT   STRAND      352    354       {ECO:0000244|PDB:2Q8H}.
FT   HELIX       358    368       {ECO:0000244|PDB:2Q8G}.
FT   STRAND      372    378       {ECO:0000244|PDB:2Q8G}.
FT   TURN        379    381       {ECO:0000244|PDB:2Q8G}.
FT   STRAND      382    392       {ECO:0000244|PDB:2Q8G}.
FT   TURN        393    395       {ECO:0000244|PDB:2Q8G}.
FT   HELIX       405    411       {ECO:0000244|PDB:2Q8G}.
SQ   SEQUENCE   436 AA;  49244 MW;  D14CD594E0EA45A2 CRC64;
     MRLARLLRGA ALAGPGPGLR AAGFSRSFSS DSGSSPASER GVPGQVDFYA RFSPSPLSMK
     QFLDFGSVNA CEKTSFMFLR QELPVRLANI MKEISLLPDN LLRTPSVQLV QSWYIQSLQE
     LLDFKDKSAE DAKAIYDFTD TVIRIRNRHN DVIPTMAQGV IEYKESFGVD PVTSQNVQYF
     LDRFYMSRIS IRMLLNQHSL LFGGKGKGSP SHRKHIGSIN PNCNVLEVIK DGYENARRLC
     DLYYINSPEL ELEELNAKSP GQPIQVVYVP SHLYHMVFEL FKNAMRATME HHANRGVYPP
     IQVHVTLGNE DLTVKMSDRG GGVPLRKIDR LFNYMYSTAP RPRVETSRAV PLAGFGYGLP
     ISRLYAQYFQ GDLKLYSLEG YGTDAVIYIK ALSTDSIERL PVYNKAAWKH YNTNHEADDW
     CVPSREPKDM TTFRSA
//
